Skip to main content
SpringerLink
Log in

Additive Therapie der Pseudomonas-Sepsis mit Pseudomonas-Immunglobulin

  • Chapter
Infektionen auf Intensivstationen

Part of the book series: Intensivmedizinisches Seminar ((INTENSIVM.SEM.,volume 3))

  • 23 Accesses

Zusammenfassung

Das Letalitätsrisiko der Pseudomonas-Sepsis gehört zu den höchsten unter den septischen Erkrankungen [9]: so betrug die Sterblichkeit in einer vor kurzem vorgestellten Untersuchung [9] an 274 Patienten 42%. Als ein Versuch, diese ernste Prognose von Patienten mit Pseudomonas-Sepsis und septischem Schock zu verbessern, sind additive, zusätzlich zu den Antibiotika eingesetzte Therapien Gegenstand experimenteller und klinischer Untersuchungen. Hierzu gehören z. B. der Einsatz von Immunglobulinen [3–6, 12, 22, 27] oder monoklonalen Antikörpern gegen Pseudomonas-Toxine [11, 14, 25, 26].

An der Studie waren beteiligt: Dr. Appelt, Kiel; Dr. Arning, Düsseldorf; Dr. Class, Stuttgart; Dr. Cremer, Hannover; Dr. Drescher, München; Dr. Dvorak-Lansloot, Hannover; Dr. Ernst, Bad Oeynhausen; Dr. Fink, München; Dr. Haferlach, Kiel; Dr. Meyer, Hannover; Dr. Nattermann, München; Dr. Pilz, München; Dr. Reuschel-Janetschek, München; Prof. Dr. Schweigart, München; Dr. Weiß, Hannover, alle: Bundesrepublik Deutschland.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Boekstegers P, Pilz G, Werdan K (1990) Comparison of skeletal muscle tissue oxygenation in patients with severe infection, septic shock and cardiogenic shock. Eur Heart J 11 [Abstr Suppl]: 248

    Google Scholar 

  2. Boekstegers P, Werdan K (1991) Muscle tissue oxygen partial pressure in patients with infection, sepsis and cardiogenic shock. In: Ehrly AM (ed) Clinical oxygen pressure measurements 1V (in press)

    Google Scholar 

  3. Böhm D (1987) Erfahrungen mit einem Pseudomonas-Immunglobulin bei beatmeten Patienten mit Pseudomonas-Pneumonie auf einer chirurgischen Intensivstation. Infection 15 [Suppl 2]: S64 - S66

    Article  PubMed  Google Scholar 

  4. Class I, Junginger W, Klöss T (1987) Einsatz von Pseudomonas-Immunglobulin bei beatmeten Patienten einer interdisziplinären chirurgischen Intensivstation. Infection 15 [Suppl 2]: S67 - S70

    Article  PubMed  Google Scholar 

  5. Class I, Schorer R (1989) Adjuvante Therapie mit Pseudomonas-Immunglobulin bei beatmeten Patienten einer operativen Intensivstation. Anästh Intensivther Notfallmed 24: 167–171

    Article  PubMed  CAS  Google Scholar 

  6. Collins MS, Roby RE (1984) Protective activity of an intravenous immune globuline (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. Am J Med 76: 168–174

    Article  PubMed  CAS  Google Scholar 

  7. Elebute EA, Stoner HB (1983) The grading of sepsis. Br J Surg 70: 29–31

    Article  PubMed  CAS  Google Scholar 

  8. Fomsgaard A, Baek L, Fomsgaard JS, Engquist A (1989) Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors. Scand J Infect Dis 21: 697–708

    Article  PubMed  CAS  Google Scholar 

  9. Gatell JH, Mallolas J (1990) Analysis of prognostic factors of Pseudomonas aeruginosa bacteremia. In: Basic Research and Clinical Aspects of Pseudomonas aeruginosa Infection. The 3rd International Symposium, Tokyo, September 12–14, 1990 (Abstract Book, p 21)

    Google Scholar 

  10. Grundmann R, Kipping N, Wesoly C (1988) Der „Sepsisscore“ von Elebute und Stoner zur Definition der postoperativen Sepsis auf der Intensivstation. Intensivmedizin 25: 268–273

    Google Scholar 

  11. Hector RF, Collins MS, Pennington JE (1989) Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody. J Infect Dis 160: 483–489

    Article  PubMed  CAS  Google Scholar 

  12. Kistler D, Kauhl W, Piert M, Rettich R (1989) Unterstützende Therapie mit einem Pseudomonas Immunglobulin beim septischen Schock von Brandverletzten. Intensivmedizin 26 [Suppl 1]: 138–143

    Google Scholar 

  13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818–829

    Article  PubMed  CAS  Google Scholar 

  14. Lang AB, Fürer E, Larrick JW, Cryz SJ (1989) Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4 and 6 lipopolysaccharides. Infect Immun 57: 3851–3855

    PubMed  CAS  Google Scholar 

  15. Müller U, Pfeifer A, Werdan K (1990) Impairment of contractile state of noradrenaline-pretreated cardiomycocytes by Pseudomonas Exotoxin A. Fur Heart J 11 [Abstr Suppl]: 279

    Google Scholar 

  16. Parker MM, Shelhamer JH, Natanson C, Ailing DW, Parillo JE (1987) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15: 923–929

    Article  PubMed  CAS  Google Scholar 

  17. Pilz G, Class I, Boekstegers P, Pfeifer A, Müller U, Werdan K (1991) Pseudomonas immunoglobulin therapy in patients with Pseudomonas sepsis and septic shock. Karger (in press)

    Google Scholar 

  18. Pilz G, Gurniak T, Bujdoso O, Werdan K (1991) A BASIC program for calculation of APACHE II score and sepsis evaluation in intensive care medicine. Comput Biol Med (in press)

    Google Scholar 

  19. Pilz G, Stäblein A, Reuschel-Janetschek E, Autenrieth G, Werdan K (1989) The use of scoring systems in patients with cardiogenic and septic shock. In: Schlag G, Redl H (eds) Progress in clinical and biological research, vol308. Second Vienna Shock Forum. Alan R Liss, New York, pp 625–631

    Google Scholar 

  20. Pilz G, Werdan K (1990) Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock. Infection 18: 253–262

    Article  PubMed  CAS  Google Scholar 

  21. Pollack M, Young LS (1979) Protective activity of antibodies to exotoxin A and lipolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest 63: 276–286

    Article  PubMed  CAS  Google Scholar 

  22. Pollack M (1983) Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. J Infect Dis 147: 1090–1098

    Article  PubMed  CAS  Google Scholar 

  23. Reithmann C, Gierschik P, Müller U, Werdan K, Jakobs KH (1990) Pseudomonas exotoxin A prevents 13-adrenoceptor-induced up-regulation of G; protein a-subunits and adenylyl cyclase desensitization in rat heart muscle cells. Mol Pharmacol 37: 631–638

    PubMed  CAS  Google Scholar 

  24. Reithmann C, Werdan K (1988) Homologous vs. heterologous desensitization of the adenylate cyclase system in heart cells. Eur J Pharmacol 154: 99–104

    Article  PubMed  CAS  Google Scholar 

  25. Sawada S, Kawamura T, Masuho Y, Tomibe K (1985) Characterization of a human monoclonal antibody against to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa. J Infect Dis 152: 965–970

    Article  PubMed  CAS  Google Scholar 

  26. Sawada S, Kawamura T, Masuho Y (1987) Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa. J Gen Microbiol 133: 3581–3590

    PubMed  CAS  Google Scholar 

  27. Stuttmann R, Hartert M, Coleman JE, Kill H, Germann G, Doehn M (1989) Prophylaxe mit einem Pseudomonas-Immunglobulin bei Brandverletzten. Intensivmedizin 26 [Suppl 1]: 130–137

    Google Scholar 

  28. Weiss C, Fleckenstein W (1986) Local tissue pO2measured with “thick” needle probes. Funktionsanalyse biologischer Systeme 15: 155–166

    Google Scholar 

  29. Werdan K, Erdmann E (1989) Preparation and culture of embryonic and neonatal heart muscle cells: modification of transport activity. In: Fleischer S, Fleischer B (eds) Methods in enzymology, vol 173. Academic Press, San Diego, pp 634–662

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik I, Klinikum Großhadern, Universität München, Bundesrepublik Deutschland

    Dr. med. G. Pilz, P. Boekstegers, A. Pfeifer, U. Müller & K. Werdan

  2. Abteilung für Anästhesiologie, Marien-Hospital Stuttgart, Bundesrepublik Deutschland

    I. Class

Authors
  1. Dr. med. G. Pilz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Class
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Boekstegers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Pfeifer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Werdan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Wien, Österreich

    Erwin Deutsch , Helmut Gadner , Wolfgang Graninger , Kurt Lenz  & Harald Andrew Zaunschirm , , ,  & 

  2. Steyr, Österreich

    Gunther Kleinberger

  3. Basel, Schweiz

    Rudolf Ritz

  4. Hildesheim, Deutschland

    Hans-Peter Schuster

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag/Wien

About this chapter

Cite this chapter

Pilz, G., Class, I., Boekstegers, P., Pfeifer, A., Müller, U., Werdan, K. (1991). Additive Therapie der Pseudomonas-Sepsis mit Pseudomonas-Immunglobulin. In: Deutsch, E., et al. Infektionen auf Intensivstationen. Intensivmedizinisches Seminar, vol 3. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9130-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9130-9_17

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82253-1

  • Online ISBN: 978-3-7091-9130-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation